In vivo studies using HLA-DQ8-susceptible mice models of RA have shown that oral administration of Prevotella histicola leads to a significant reduction in pro-inflammatory cytokines, including IL-2, IL-17, and TNF-α. The gene discussed is IL2; the disease is rheumatoid arthritis.